Alimera Sciences reported $8.56M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Alimera Sciences ALIM:US $ 8.56M 128K
Applied Genetic Technologies AGTC:US $ 3.68M 207K
Bayer BAYN:GR 3.77B 19M
Insmed INSM:US $ 60.28M 3.1M
Novartis NOVN:VX 3.6B 109M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M